Patients with endometriosis face significantly higher risks of postoperative complications when undergoing surgery for stage I endometrial cancer, according to a new study presented at the Society of...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
A real-world retrospective study found that adding GLP-1 receptor agonists to hormone therapy may reduce endometrial cancer risk in women with benign uterine or endometrial hyperplasia. This study was...
Researchers set out to determine whether short-course vaginal cuff brachytherapy regimen maintains quality of life and acceptable toxicity in patients with early-stage endometrial cancer.
A phase 3 trial subgroup analysis found that adding pembrolizumab to adjuvant chemotherapy may improve disease-free survival in patients with mismatch repair-deficient endometrial cancer, a population at...
A randomized trial found that radiation therapy alone provides better progression-free survival and fewer acute toxicities than chemoradiation for women with localized recurrent endometrial cancer.
New findings from the Women’s Health Initiative trials provide long-term insights into the effects of hormone therapy regimens on ovarian and endometrial cancer incidence and mortality.
Researchers developed a cross-sectional survey to understand the public and provider awareness of postmenopausal bleeding as a symptom of endometrial cancer.
